Uliledlimab

DB16675InvestigationalProtein Based Therapies

Uliledlimab is under investigation in clinical trial NCT04322006 (A Phase I/II Study of TJ004309 for Advanced Solid Tumor).

Mechanism
Curator reviewed
Code names
TJ-004309 · TJ-D5

Resolves to

Compound
UNII3OX1DBR75GCAS2378407-27-1
Targets
P21589NT5E

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Uliledlimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In